FDA 510(k)

GORE SYNECOR Preperitoneal Biomaterial

K-Number: K163576 · 2017-05-11

Decision Date2017-05-11

Product CodeFTL

Advisory CommitteeSU

DecisionSubstantially Equivalent

Device Summary

GORE SYNECOR Preperitoneal Biomaterial is the device name listed in this FDA 510(k) record. The listed applicant is W. L. Gore & Associates, Inc.. It received FDA 510(k) clearance on 2017-05-11 under 510(k) number K163576. The device is classified under product code FTL. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the GORE SYNECOR Preperitoneal Biomaterial?

GORE SYNECOR Preperitoneal Biomaterial is a medical device that received FDA 510(k) clearance on 2017-05-11. The listed applicant is W. L. Gore & Associates, Inc.. The 510(k) number is K163576.

When did GORE SYNECOR Preperitoneal Biomaterial receive FDA 510(k) clearance?

GORE SYNECOR Preperitoneal Biomaterial received FDA 510(k) clearance on 2017-05-11, under 510(k) number K163576.

Who is the listed applicant for GORE SYNECOR Preperitoneal Biomaterial?

The FDA 510(k) record lists W. L. Gore & Associates, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for GORE SYNECOR Preperitoneal Biomaterial?

The FDA product code for GORE SYNECOR Preperitoneal Biomaterial is FTL.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT04718168GORE® ENFORM Biomaterial Product StudyRECRUITING NCT02380716ARISE: Evaluation of the GORE® Ascending Stent Graft in the Treatment of DeBakey Type I/II Aortic DissectionCOMPLETED NCT03728985Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic AneurysmsACTIVE_NOT_RECRUITING NCT03821129GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRECRUITING NCT04100135GORE® CARDIOFORM Septal Occluder Migraine Clinical StudyTERMINATED NCT04907240Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global RegistryACTIVE_NOT_RECRUITING

Other records listing W. L. Gore & Associates, Inc. as applicant

PMA P050006Transcatheter septal occluder PMA P210032SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT PMA P020004SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT PMA P230023Endovascular system for treatment of thoracoabdominal and pararenal aortic lesions PMA P160021Iliac covered stent, arterial PMA P130006System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment

View all 24 devices →

Related Devices (Code: FTL)

K253956ProGrip™ advanced self-gripping polypropylene mesh (ADG1510, ADG2015, ADG3020, ADG4030)Sofradim Production K253125Parietene™ Flat Sheet MeshMedtronic - Sofradim Production K251955Onflex™ MeshDavol Inc., Subsidiary of C. R. Bard, Inc.K251557Bard® Mesh; Bard® Mesh Pre-ShapedDavol, Inc.K250869Parietene™ Macroporous Mesh (PPM5050 )Sofradim Production K250098Bard Soft Mesh; Bard Soft Mesh Pre-ShapedDavol, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.